Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

About this trial

The high incidence and variety of conduction disturbances post-TAVR represents a major challenge in the periprocedural management of TAVR recipients. Despite the growing body of knowledge on this topic, the large variability in the management of these complications has translated into a high degree of uncertainty regarding the most appropriate treatment of a large proportion of such patients. The implementation of a pre-specified treatment strategy translating into a more uniform practice regarding the management of conduction disturbances post-TAVR applied to a large cohort of patients would permit to identify the benefits and drawbacks of each specific aspect of the treatment algorithm proposal. This may also help to improve both the management and clinical outcomes of the complex group of patients with conduction disturbances associated with TAVR. In the end, the final objective of a pre-specified strategy for managing conduction disturbances post-TAVR should be to obtain a low rate of PPM without increasing the risk of sudden death or life threatening arrhythmic events following hospital discharge, and all this while avoiding an excessive prolongation of the hospitalization period following the TAVR procedure.

Eligibility criteria

Qualifiers

None

Disqualifiers

Prior permanent pacemaker

Failure to provide signed informed consent for data collection

Impossibility for a follow-up

Unwillingness to follow the pre-specified strategy for the management of conduction disturbances

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,000 Participants
are grouped into 5 trial groups